Webinar recordings

QIAGEN Clinical Insight (QCI) Interpret identifies targeted therapy and clinical trials in hematological tumors

December 08, 2016
Hematological malignancies originating from hematopoietic and lymphoid tissue are complex heterogeneous diseases characterized by distinct clinicopathological features and molecular alterations. The heterogeneity of leukemia and lymphoma has presented massive challenges for identifying the appropriate treatment for each patient. Advances in next-generation sequencing (NGS) have presented unique treatment opportunities beyond standard of care and chemotherapy. QIAGEN® Clinical Insight (QCI™ Interpret) is a web-based application for the annotation, classification, and reporting of clinically actionable variants from NGS data in clinical genomics laboratories.

Related videos

Webinar recordings

Clinical Metagenomics for Rapid Detection of Enteric Pathogens and Characterization of the...

535 views December 20, 2016

High-throughput sequencing, combined with high-resolution metagenomic...

Webinar recordings

Part 1: Use of QCI Interpret to elucidate precision in breast cancer targeted therapy

482 views October 24, 2016

Breast cancer is a complex heterogeneous disease, with each subtype...

Webinar recordings

Taxonomic profiling using shotgun metagenome data

516 views April 24, 2017

In this webinar, we will introduce the latest workflows optimized for shotgun...